RU96104214A - METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES - Google Patents

METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES

Info

Publication number
RU96104214A
RU96104214A RU96104214/14A RU96104214A RU96104214A RU 96104214 A RU96104214 A RU 96104214A RU 96104214/14 A RU96104214/14 A RU 96104214/14A RU 96104214 A RU96104214 A RU 96104214A RU 96104214 A RU96104214 A RU 96104214A
Authority
RU
Russia
Prior art keywords
treating
forms
dystrophies
central
transsudative
Prior art date
Application number
RU96104214/14A
Other languages
Russian (ru)
Other versions
RU2120264C1 (en
Inventor
И.А. Мазур
Б.С. Безуглый
Е.В. Буянова
Л.Э. Саржевская
Н.А. Волошин
Original Assignee
И.А. Мазур
Filing date
Publication date
Application filed by И.А. Мазур filed Critical И.А. Мазур
Priority to RU96104214A priority Critical patent/RU2120264C1/en
Priority claimed from RU96104214A external-priority patent/RU2120264C1/en
Publication of RU96104214A publication Critical patent/RU96104214A/en
Application granted granted Critical
Publication of RU2120264C1 publication Critical patent/RU2120264C1/en

Links

Claims (2)

1. Способ лечения транссудативных форм центральных хориоретинальных дистрофий посредством введения лекарственного средства, отличающийся тем, что в качестве лекарственного средства используют раствор тиотриазолина, вводимый в глаз парабульбарно.1. A method of treating transudative forms of central chorioretinal dystrophies by administering a medicament, characterized in that a thiotriazoline solution administered parabulbularly into the eye is used as a medicament. 2. Способ по п.1, отличающийся тем, что используют 1%-ный раствор тиотриазолина по 0,5 мл 1 раз в день в течение 10 - 14 дней. 2. The method according to claim 1, characterized in that they use a 1% solution of thiotriazolin 0.5 ml once a day for 10 to 14 days.
RU96104214A 1996-03-04 1996-03-04 Method for treating transsudative forms of central chorioretinal dystrophy RU2120264C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96104214A RU2120264C1 (en) 1996-03-04 1996-03-04 Method for treating transsudative forms of central chorioretinal dystrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96104214A RU2120264C1 (en) 1996-03-04 1996-03-04 Method for treating transsudative forms of central chorioretinal dystrophy

Publications (2)

Publication Number Publication Date
RU96104214A true RU96104214A (en) 1998-06-10
RU2120264C1 RU2120264C1 (en) 1998-10-20

Family

ID=20177668

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96104214A RU2120264C1 (en) 1996-03-04 1996-03-04 Method for treating transsudative forms of central chorioretinal dystrophy

Country Status (1)

Country Link
RU (1) RU2120264C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2711543C1 (en) * 2019-02-20 2020-01-17 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Method of treating experimental chemical burns and cataracts modeled on chinchillas rabbits

Similar Documents

Publication Publication Date Title
RU94016393A (en) PEPTIDES possessing the ability to stimulate the growth of the growth hormone, method of production, pharmaceutical composition, method of treatment
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
MX9203543A (en) MEDICINE.
DK0869808T3 (en) Use of Glu-Trp dipeptides for the preparation of a drug for the treatment of various conditions involving neovascularization
CA2122612A1 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
DE69230112D1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
TR199801180T2 (en) New compounds with analgesic effect.
BR0013065A (en) Method and compound to treat a disease associated with aberrant leukocyte recruitment and / or activation
KR870007118A (en) Optically pure compound and preparation method thereof
DE69007065T2 (en) Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases.
TR199801184T2 (en) New compounds with analgesic action.
ATE5256T1 (en) PHENYLPIPERAZIN DERIVATIVES OF 1,3,4OXADIAZOLYLPENOLS, THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM.
RU96104214A (en) METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
ATE275953T1 (en) 2,3 DIARYL-1-BENZOPYRAMES FOR THE TREATMENT OF DERMATITIS
FR2375225A1 (en) NEW BASICALLY SUBSTITUTED O-PROPYLOXIMES, THEIR METHOD OF PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
LV11524A (en) Use of benzidamine as a treatment for pathological conditions induced by TNF
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU96122561A (en) METHOD FOR COMPLEX THERAPY OF DISEASES
RU94013606A (en) Hemostimulator
RU96124465A (en) METHOD FOR TREATMENT OF PERSISTENT DISADAPTATION PSYCHOPHETIC DISORDERS
RU96122371A (en) METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE ANALYSIS
FR2653662B1 (en) APPLICATION OF N-METHYL (PYRIDYL-3) -2 TETRAHYDROTHIOPYRANNE-CARBOTHIOAMIDE-2-OXIDE-1 TO THE PREPARATION OF MEDICINES FOR THE TREATMENT OF CORONARY INSUFFICIENCY.